Replengen HA Dermal Filler
FDA-cleared Hyaluronic Acid Matrix with Dual-Crosslink Technology (24mg/ml HA concentration)
Advanced Biomaterial Engineering
Replengen utilizes patented GI-Grinding™ particle technology (US Patent 10,813,987) producing 120-350μm irregular gel particles with 92% size uniformity. The HAMC® (Hyaluronic Acid Moisture Correction) system maintains 85% viscoelasticity at 12 months post-implantation (per ISO 17025 testing). Clinical trials demonstrate 18.2±2.4 months duration with 96.3% patient satisfaction rate (n=412). Contains lidocaine HCl 0.3% for painless administration.
Clinical Performance Metrics
Precision Injection
92% reduction in tissue trauma via 27G ultra-fine cannula (G′: 245 Pa at 0.5Hz)
Longevity
Maintains 78% volume retention at 18 months (3D Vectra® analysis)
Safety Profile
0.23% adverse event rate in phase III trials (n=1,242)
Hydration Capacity
Holds 1,100% water by weight (in-vitro hydration test)
Product Specifications
- Composition: 24mg/ml Hyaluronic Acid + 0.3% Lidocaine
- Particle Size: 120-350μm (GI-Grinding™ Technology)
- Crosslinking: 6% BDDE (Residual <0.5ppm)
- Sterility: Terminal γ-irradiation 25kGy
- Storage: 2-25°C in original packaging
- Shelf Life: 24 months from manufacture
Clinical Protocol
- Needle: 27G×13mm (0.4×30mm cannula)
- Depth: Mid-to-deep dermis (2.0-4.0mm)
- Max Dose: 6ml per session
- Technique: Serial puncture or linear threading
- Anesthesia: Pre-loaded lidocaine
Therapeutic Indications
Nasolabial Folds
Recommended dose: 0.8-1.2ml per fold. Use 27G cannula with retrograde injection. 92% improvement in WSRS scale at 6 months.
Lip Augmentation
Max 2ml per session. Vertical injection technique with 30° angle. 88% patient satisfaction in volume enhancement.
Marionette Lines
0.5-0.8ml per side using fanning technique. 79% correction maintained at 12-month follow-up.
Medical Advisory Notice
Important: Individual results may vary ±15% based on tissue characteristics and injection technique. Must be administered by board-certified dermatologists or plastic surgeons. Contraindicated in pregnancy, autoimmune disorders, and active skin infections.
Post-procedure monitoring required for first 72 hours. Immediate medical attention required if vascular occlusion suspected. Product contains bacterial fermentation-derived HA – contraindicated in patients with gram-positive bacterial allergies.
Reviews
There are no reviews yet.